PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A potentially life-saving protein takes shape

Ubiquitin's novel forms suggest novel functions

2013-07-02
(Press-News.org) COLLEGE PARK, MD - A tiny protein called ubiquitin – so named because it is present in every cell of living things as dissimilar as hollyhocks and humans - may hold the key to treatment for a variety of diseases from Parkinson's to diabetes. The protein, found in all eukaryotes (organisms with membranous cells), was considered unimportant when it was described in 1975. But scientists now know ubiquitin takes many different forms and is important in basic cellular processes, from controlling cells' circadian clocks to clearing away the harmful build-up of cells found in cancer and other diseases.

To maximize ubiquitin's potential for treating diseases, researchers are working to identify the protein's dizzying array of structures, and to understand each form's function. Ubiquitin forms polymeric chains linked by specific amino acids. Each ubiquitin protein can connect to its neighbor through one of eight different amino acids, and each combination appears to do something different in a normal cell, says University of Maryland structural biologist David Fushman, whose lab studies these ubiquitin chains and their linkages.

Imagine the cell as a dance floor, thronged with proteins seeking partners, says Fushman, who has studied ubiquitin since 2000. When two ubiquitins join through a lysine, "it's like two hands meeting, but with just a single finger touching that's specific to that lysine." The choice of lysine determines the shape of the ubiquitin chain, and probably also determines its function.

Fushman and his colleagues' newly published research focuses on one of the most common and least studied linkages, the polymeric chain formed by the amino acid Lysine-11. The ubiquitin chains linked by Lysine-11 "are directly involved in cell cycle regulation," Fushman says. To turn that knowledge into medically useful information, "we have to understand exactly how they form and with whom they interact."

Most work of this type is done in a test tube and uses x-ray crystallography to map the structures. Fushman's lab uses a different method that he says produces an environment somewhat closer to nature. The team used nuclear magnetic resonance spectroscopy (NMR) and other techniques to map the Lysine-11-linked chains.

The researchers found these chains take on a different shape in solution than in crystals, and are more flexible than was previously thought. Ubiquitin chains linked via Lysine-11 can form various three-dimensional shapes, and as salt concentrations change, the chains' shape also changes, the team found.

Researcher Carlos Castañeda and others in the Fushman lab reported their results in a paper published July 2 in the biological journal Structure.

The most-studied ubiquitin chain, linked via Lysine-48, is known as a "protein destroyer" because it labels cellular proteins to be broken up for later recycling. The UMD team found the cellular receptors responsible for breaking down proteins interact with Lysine-11 chains, but not as efficiently as with Lysine-48 chains. Therefore protein destruction does not appear to be the main task of the Lysine-11 linked chain, Fushman says; its function is something different and perhaps equally vital to maintaining healthy cells.

### Carlos A. Castañeda, Tanuja R. Kashyap, Mark A. Nakasone, Susan Krueger and David Fushman, "Unique structural, dynamical, and functional properties of K11-linked polyubiquitin chains" published in Structure, July 2, 2013

Media contact: Heather Dewar
301-405-9267


ELSE PRESS RELEASES FROM THIS DATE:

UNC researchers discover a gene's key role in building the developing brain's scaffolding

2013-07-02
CHAPEL HILL, N.C. -- Researchers have pinpointed the role of a gene known as Arl13b in guiding the formation and proper placement of neurons in the early stages of brain development. Mutations in the gene could help explain brain malformations often seen in neurodevelopmental disorders. The research, led by a team at the University of North Carolina School of Medicine, was published June 30 in the journal Nature Neuroscience. "We wanted to get a better sense of how the cerebral cortex is constructed," said senior study author Eva Anton, PhD, a professor in the Department ...

Gene therapy cures a severe paediatric neurodegenerative disease in animal models

2013-07-02
Sanfilippo Syndrome type A, or Mucopolysaccharidosis type IIIA (MPSIIIA), is a neurodegenerative disease caused by mutations in the gene that encodes the enzyme sulfamidase. Mutations in this gene lead to deficiencies in the production of the enzyme, which is essential for the breakdown of substances known as glycosaminoglicans. If these substances are not broken down, they accumulate in the cells and cause neuroinflammation and organ dysfunction, mainly in the brain, but also in other parts of the body. Children born with this mutation are diagnosed from the age of 4 or ...

GIS scientists discover molecular communication network in human stem cells

2013-07-02
Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell. Human embryonic stem cells have the remarkable property that they can form all human cell types. Scientists around the world study these cells to be able to use them for medical applications in the future. ...

Fishing in the sea of proteins

2013-07-02
To convert a gene into a protein, a cell first crafts a blueprint out of RNA. One of the main players in this process has been identified by researchers led by Dr. Jessica Jacobs at the Ruhr-Universität Bochum. The team "fished" a large complex of proteins and RNA, which is involved in the so-called splicing, from the chloroplasts of the green alga Chlamydomonas reinhardtii. This cuts non-coding regions out of the messenger RNA, which contains the protein blueprint. "For the first time, we have established the exact composition of an unknown splicing complex of the chloroplasts", ...

Changes in hyaluronan metabolism key in adaptation of keratinocytes to radiation injury

2013-07-02
As the outermost layer of skin, epidermis is crucial in forming a permeability barrier and protection against various environmental agents. Thus, investigating the biology of its most important cell type, the keratinocyte, is key to understanding the effects of solar ultraviolet radiation in skin, and helps design effective means of protection against excessive exposure. It has already previously been shown with both cell culture and in vivo animal models that UV irradiation increases the expression of hyaluronan, which is an important carbohydrate of the extracellular ...

Cadaver study may help clinicians identify patients who can skip ACL reconstruction

2013-07-02
A study by researchers at Hospital for Special Surgery has provided the first evidence that the shape of a person's knee could be a factor in the decision of whether a patient should undergo anterior cruciate ligament (ACL) reconstruction after an ACL tear. The study is published online ahead of print in the Proceedings of the Institution of Mechanical Engineering. "This is the first study to show that after your ACL is ruptured, the changes in the mechanics of the knee can really be affected by the shape of the knee," said Suzanne Maher, Ph.D., associate director of ...

Fidaxomicin in Clostridium difficile infection: added benefit not proven

2013-07-02
The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults who have diarrhoea caused by Clostridium difficile. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of fidaxomicin in comparison with current standard therapy. According to this, there is currently no proof of an added benefit. The manufacturer did not submit any studies on non-severe ...

Abiraterone: Hint of considerable added benefit

2013-07-02
Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether abiraterone offers an added benefit compared with the present standard therapy. ...

The ribosome -- a new target for antiprion medicines

2013-07-02
New research results from Uppsala University, Sweden, show that the key to treating neurodegenerative prion diseases such as mad cow disease and Creutzfeldt-Jakob disease may lie in the ribosome, the protein synthesis machinery of the cell. The results were recently published in the Journal of Biological Chemistry. Prion diseases are fatal neurodegenerative diseases caused by misfolding of prion proteins. Examples of prion diseases are scrapie in sheep, mad cow disease and Creutzfeldt-Jakob disease in human. What triggers misfolding of the prion proteins to the amyloid ...

Companies look at wrong things when using facebook to screen job applicants

2013-07-02
Employers are increasingly using Facebook to screen job applicants and weed out candidates they think have undesirable traits. But a new study from North Carolina State University shows that those companies may have a fundamental misunderstanding of online behavior and, as a result, may be eliminating desirable job candidates. Researchers tested 175 study participants to measure the personality traits that companies look for in job candidates, including conscientiousness, agreeableness and extraversion. The participants were then surveyed on their Facebook behavior, allowing ...

LAST 30 PRESS RELEASES:

Male flies sharpened their eyesight to call the females' bluff

School bans alone not enough to tackle negative impacts of phone and social media use

Explaining science in court with comics

‘Living’ electrodes breathe new life into traditional silicon electronics

One in four chance per year that rocket junk will enter busy airspace

Later-onset menopause linked to healthier blood vessels, lower heart disease risk

New study reveals how RNA travels between cells to control genes across generations

Women health sector leaders good for a nation’s wealth, health, innovation, ethics

‘Good’ cholesterol may be linked to heightened glaucoma risk among over 55s

GLP-1 drug shows little benefit for people with Parkinson’s disease

Generally, things really do seem better in morning, large study suggests

Juicing may harm your health in just three days, new study finds

Forest landowner motivation to control invasive species depends on land use, study shows

Coal emissions cost India millions in crop damages

$10.8 million award funds USC-led clinical trial to improve hip fracture outcomes

University Hospitals Cleveland Medical Center among most reputable academic medical centers

Emilia Morosan on team awarded Kavli Foundation grant for quantum geometry-enabled superconductivity

Unlock sales growth: Implement “buy now, pay later” to increase customer spending

Research team could redefine biomedical research

Bridging a gap in carbon removal strategies

Outside-in signaling shows a route into cancer cells

NFL wives bring signature safe swim event to New Orleans

Pickleball program boosts health and wellness for cancer survivors, Moffitt study finds

International Alzheimer’s prevention trial in young adults begins

Why your headphone battery doesn't last

Study probes how to predict complications from preeclampsia

CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

NYU’s Yann LeCun a winner of the 2025 Queen Elizabeth Prize for Engineering

New study assesses impact of agricultural research investments on biodiversity, land use

High-precision NEID spectrograph helps confirm first Gaia astrometric planet discovery

[Press-News.org] A potentially life-saving protein takes shape
Ubiquitin's novel forms suggest novel functions